Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. sphingotec.comSphingoTec - The Biomarker Company - sphingotec.com

   sphingotec.com

   • Im Cache

   SphingoTec Announces Management Changes. SphingoTec is pleased to announce the following appointments to its management team: Deborah Bergmann as Managing Director and Chief Executive Officer (CEO), Dr. Florian Uhle as Managing Director and Chief Medical Officer (CMO) and Nicole Witzmann as Chief Financial Officer (CFO). 05.

   • Blog

     Current applications of precision medicine in intensive care...

   • Order

     Disclaimer: Sphingotest ® penKid ® and sphingotest ® bio-ADM...

   • Products

     The microtiter plate is a standard tool in analytical...

   • Collaboration

     SphingoTec develops and markets innovative biomarkers for...

2. de.linkedin.com › company › sphingotecSphingoTec | LinkedIn

   de.linkedin.com › company › sphingotec

   SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in...

3. sphingotec.com › newsNews - sphingotec.com

   sphingotec.com › news

   • Im Cache

   26. März 2024 · This section contains all current press releases on topics and news items concerning SphingoTec. Do you want to stay informed of our latest news?

4. twitter.com › sphingotec@sphingotec | Twitter

   twitter.com › sphingotec

   Die neuesten Tweets von @sphingotec

5. sphingotec.com › companyAbout Us - sphingotec.com

   sphingotec.com › company

   • Im Cache

   SphingoTec is a privately held company with its headquarter in Hennigsdorf near Berlin and with a wholly-owned subsidiary in San Diego, USA. The headquarter has a long history of biomarker discovery, development, and validation and is the legal manufacturer of the microtiter plate assays. The German company is leading the global commercialization of diagnostic solutions with a clear goal ...

   • 
   • 
   • 
   • 
   • 

6. www.dbi-ag.de › aktuelles › pressemitteilungenPressemitteilung Beteiligungsunternehmen Sphingotec GmbH - DBI)...

   www.dbi-ag.de › aktuelles › pressemitteilungen

   • Im Cache

   Hennigsdorf/Berlin, Deutschland, 11 April 2022 – Das Diagnostikunternehmen SphingoTec GmbH (SphingoTec) gibt die Anwendung von zwei Biomarkern zur Steuerung eines neuen Covid-19 Medikamentenkandidats bekannt. Der Medikamentenkandidat wird in einer Studie des UKEs zur Anwendung in mittelschwer- und schwerkranken Patienten und Patientinnen erprobt.

7. www.kununu.com › de › sphingotecSphingoTec als Arbeitgeber: Gehalt, Karriere, Benefits

   www.kununu.com › de › sphingotec

   • Im Cache

   Ist SphingoTec GmbH der richtige Arbeitgeber für Dich? Anonyme Erfahrungsberichte zu Gehalt, Kultur und Karriere von Mitarbeitern und Bewerbern findest Du hier.